Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Ionis Pharmaceuticals Inc (NASDAQ: IONS) closed at $32.75 in the last session, down -0.97% from day before closing price of $33.07. In other words, the price has decreased by -$0.97 from its previous closing price. On the day, 1.92 million shares were traded.
Ratios:
We take a closer look at IONS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.62 and its Current Ratio is at 9.66. In the meantime, Its Debt-to-Equity ratio is 4.12 whereas as Long-Term Debt/Eq ratio is at 4.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 07, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On March 31, 2025, Redburn Atlantic started tracking the stock assigning a Neutral rating and target price of $39.
BMO Capital Markets Downgraded its Outperform to Market Perform on August 02, 2024, whereas the target price for the stock was revised from $67 to $60.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 01 ’25 when Hayden Michael R bought 15,000 shares for $31.86 per share. The transaction valued at 477,900 led to the insider holds 50,219 shares of the business.
Birchler Brian sold 680 shares of IONS for $19,292 on Apr 16 ’25. The EVP, Corp and Development Ops now owns 56,660 shares after completing the transaction at $28.37 per share. On Apr 16 ’25, another insider, Jenne Kyle, who serves as the EVP, Chf GL Pdt Str Ofcr of the company, sold 3,016 shares for $28.36 each. As a result, the insider received 85,534 and left with 11,199 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.26 while its Price-to-Book (P/B) ratio in mrq is 10.95.
Stock Price History:
Over the past 52 weeks, IONS has reached a high of $52.34, while it has fallen to a 52-week low of $23.95. The 50-Day Moving Average of the stock is 5.93%, while the 200-Day Moving Average is calculated to be -11.67%.
Shares Statistics:
A total of 159.04M shares are outstanding, with a floating share count of 154.76M. Insiders hold about 2.76% of the company’s shares, while institutions hold 100.40% stake in the company.
